Stryker Corporation (SYK)
NYSE: SYKHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:01 PM ET · Delayed 15 min
SYK stock chart
Technical analysisKey statistics
All statistics- Market cap
- $118.01B
- P/E (TTM)
- 33.01
- Forward P/E
- 19.03
- EPS (TTM)
- $9.39
- Dividend yield
- 1.14% ($3.52)
- Ex-dividend date
- Sep 30, 2026
- 52-week range
- 267.00 – 389.33
- Day range
- 308.82 – 320.97
- Volume / Avg
- 2.38M / 2.93M
- Beta
- —
- Shares outstanding
- 380.69M
52-week range
SYK stock today
Stryker (SYK) closed at $310.00 on Nov 20, down 0.98% (-$3.08), versus the S&P 500's 3.70% decline. Shares are 20.4% below their 52-week high of $389.33, set on Mar 2, 2026 and 16.1% above the 52-week low of $267.00, in the middle of the past year's range. SYK is down 11.8% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 15.8%.
At 33.0x trailing earnings, Stryker trades in line with the peer-group median of 36.6x. Its forward P/E of 19.0x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Stryker pays an annual dividend of $3.52 per share, a 1.14% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About Stryker
Company profileStryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Kevin A. Lobo
- Headquarters
- Portage, MI
- Employees
- 56,000
- Website
- stryker.com
Financial highlights
Full financialsIn fiscal 2025, Stryker generated $25.12 billion in revenue, up 11.2% from fiscal 2024, its 5th consecutive year of revenue growth. Net income was $3.25 billion (+8.5% year over year), for a net margin of 12.9% versus a median of 12.8% in the prior 5 years. Gross margin was 64.0% (up from 63.9%) and operating margin 19.5%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $25.12B | $22.59B | $20.50B | $18.45B | $17.11B |
| Growth | +11.16% | +10.23% | +11.11% | +7.84% | +19.21% |
| Net income | $3.25B | $2.99B | $3.17B | $2.36B | $1.99B |
| EPS (diluted) | $8.40 | $7.76 | $8.25 | $6.17 | $5.21 |
Analyst forecast
ForecastConsensus (30 analysts)
buy
Avg. price target
$339.37+9.47%
- Strong buy 8
- Buy 14
- Hold 8
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Oct 29, 2026
- EPS actual vs est.
- $3.19 vs $3.56
- Surprise
- -10.39%
Dividends
Dividend history- Annual dividend
- $3.52
- Dividend yield
- 1.14%
- Last payment
- $0.88
- Ex-dividend date
- Sep 30, 2026
SYK news
All SYK news- Stryker: A Great Franchise Still Has Something To ProveSeeking Alpha
- Stryker Sticks to Growth Goals Despite Cyberattack and Slower Orthopedic MarketNasdaq
- General Dynamics wins $332.5M Army contract for Stryker supportSeeking AlphaGD, SYK
- ISRG EPS Climbs 25% to $3: Is Innovation Driving Profitable Growth?NasdaqISRG, MDT, SYK
- Stryker Corporation (SYK) Presents at Jefferies Global Healthcare Conference 2026 TranscriptSeeking Alpha
- GEHC or SYK: Which Is the Better Value Stock Right Now?NasdaqGEHC, SYK
- Why did Stryker surge 19% after cutting full-year guidance?Investing.com
- Stryker Corporation Increases Board Size to 12 and Elects James E. DavisNasdaq
Stryker peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| MMM3M Company | 177.99 | -0.27% | $91.97B | vs SYK |
| BSXBoston Scientific Corporation | 41.98 | -2.35% | $60.85B | vs SYK |
| BDXBecton Dickinson and Company | 212.78 | +0.05% | $57.96B | vs SYK |
| MDLNMedline Inc. Class A | 37.04 | -2.11% | $48.75B | vs SYK |
| RMDResMed Inc. | 235.63 | -0.53% | $33.14B | vs SYK |
| DXCMDexCom Inc. | 79.32 | -1.08% | $29.58B | vs SYK |
| WSTWest Pharmaceutical Services Inc. | 390.30 | -1.61% | $27.19B | vs SYK |
| SOLVSolventum Corporation | 84.50 | -1.52% | $14.36B | vs SYK |
Indexes, lists and sector
Stryker stock FAQ
What is Stryker's stock price today?
SYK last traded at $310.00 as of Nov 20, 4:01 PM EST, down 0.98% on the day. Prices are delayed at least 15 minutes.
Does Stryker pay a dividend?
Yes. Stryker pays $3.52 per share annually, a 1.14% yield. The most recent dividend of $0.88 had an ex-dividend date of Sep 30, 2026.
What is SYK's P/E ratio?
SYK trades at a trailing P/E ratio of 33.01 and a forward P/E of 19.03, compared with a median of 36.6 for its closest peers.
Is Stryker in the S&P 500?
Yes. Stryker (SYK) is a constituent of the S&P 500 index.
Who is Stryker's CEO?
Mr. Kevin A. Lobo is the chief executive officer of Stryker Corporation, which has about 56,000 employees.
Has SYK ever split its stock?
Yes. The most recent SYK stock split was a 2-for-1 split on May 17, 2004, one of 9 splits on record.
What is the SYK 52-week high?
The 52-week high for SYK is $389.33 and the 52-week low is $267.00. The stock is currently 20.4% below its high.